Results 11 to 20 of about 541,955 (303)

Ataxic gait [PDF]

open access: yesClinical Case Reports, 2021
Abstract Ataxia as the main complaint in a young patient prompts to diagnose neurodegenerative diseases. Not all ataxias are irreversible. We present a video of a patient in the clinic with ataxia diagnosed as subacute combined degeneration of the cord.
Shalini Bhaskar   +2 more
openaire   +3 more sources

Gait‐D: Skeleton‐based gait feature decomposition for gait recognition [PDF]

open access: yesIET Computer Vision, 2021
Abstract The general silhouette‐based gait recognition methods usually rely on binary human silhouette, which is easily affected by external factors, making it unsuitable for situations while wearing heavy clothes or carrying objects, etc. In this study, a new skeleton‐based gait recognition model is proposed. The model first extracts
Shuo Gao 0003   +3 more
openaire   +2 more sources

Toe-walking in heterozygous carriers of McArdle disease

open access: yesЛечащий Врач, 2022
McArdle disease (glycogen storage disease type V) is a metabolic myopathy often onset in the first decade of life. The main symptoms of the disease include myalgia and fatigue in the first few minutes of exercise, as well as its intolerance, including ...
D. Pomarino   +3 more
doaj   +1 more source

Foot Assessment Clinical Scales in Charcot-Marie-Tooth Patients: A Scoping Review

open access: yesFrontiers in Human Neuroscience, 2022
IntroductionCharcot-Marie-Tooth disease (CMT) is a slow and progressive peripheral motor sensory neuropathy frequently associated with the cavo-varus foot deformity.
Chiara Rambelli   +10 more
doaj   +1 more source

IN VITRO AND IN VIVO EFFICIENCY OF EUPHORBIA ANTIQUORUM AS ANTIOXIDANT AND HEPATOPROTECTIVE AGAINST CCL4 – HEPATIC HAZARDS IN RATS. [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2012
The aqueous extract of the aerial parts of Euphorbia antiquorum (EA) Linn was evaluated for its in vitro antioxidant efficiency as well as in vivo hepatoprotective and antioxidant activity to validate its use in traditional therapeutic medications.
Mansour Gait
doaj   +1 more source

Indices of Loading and Propulsive Ability in the Gait of Patients With Chronic Stroke With Equinus Foot Deviation: A Correlation Study

open access: yesFrontiers in Human Neuroscience, 2022
In literature, indices of overall walking ability that are based on ground reaction forces have been proposed because of their ease of administration with patients.
Davide Mazzoli   +9 more
doaj   +1 more source

Feasibility and outcomes of supplemental gait training by robotic and conventional means in acute stroke rehabilitation

open access: yesJournal of NeuroEngineering and Rehabilitation, 2023
Introduction Practicality of implementation and dosing of supplemental gait training in an acute stroke inpatient rehabilitation setting are not well studied but can have positive impact on outcomes.
Mukul Talaty, Alberto Esquenazi
doaj   +1 more source

Surgical quadriceps lengthening can reduce quadriceps spasticity in chronic stroke patients. A case-control study

open access: yesFrontiers in Neurology, 2022
BackgroundMuscle overactivity is one of the positive signs of upper motor neuron lesions. In these patients, the loss of muscle length and extensibility resulting from soft tissue rearrangement has been suggested as a contributing cause of muscle ...
Andrea Merlo   +9 more
doaj   +1 more source

Three-Dimensional Gait Analysis in Children Undergoing Gastrocsoleus Lengthening for Equinus Secondary to Cerebral Palsy

open access: yesMedicina, 2021
Background and Objectives: Equinus is the most common deformity in children with cerebral palsy, and surgical lengthening of the gastrocsoleus muscle-tendon unit is the most commonly performed operation for children with cerebral palsy.
Norine Ma   +5 more
doaj   +1 more source

Transcranial direct current stimulation combined with physical or cognitive training in people with Parkinson’s disease: a systematic review

open access: yesJournal of NeuroEngineering and Rehabilitation, 2020
Background Pharmacologic therapy is the primary treatment used to manage Parkinson’s disease (PD) symptoms. However, it becomes less effective with time and some symptoms do not respond to medication.
Victor Spiandor Beretta   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy